Figure 7

Low-expression of miR-33a predicts poor prognosis in NSCLC patients.
(A) Relative miR-33a expression levels were measured in 53 pairs of NSCLC tumor and non-tumor tissue samples by real-time quantitative RT-PCR. (B) The association of local invasion and overall survival in NSCLC patients. (C) The expression level of miR-33a in relation to overall survival in NSCLC patients. ***P < 0.001.